Summary of Notifiable Diseases — United States, 2007

Total Page:16

File Type:pdf, Size:1020Kb

Summary of Notifiable Diseases — United States, 2007 Morbidity and Mortality Weekly Report www.cdc.gov/mmwr Weekly Published July 9, 2009, for 2007 / Vol. 56 / No. 53 Summary of Notifiable Diseases — United States, 2007 Department Of Health And Human Services Centers for Disease Control and Prevention MMWR The MMWR series of publications is published by the Coordinating CONTENTS Center for Health Information and Service, Centers for Disease Preface ..................................................................................... 2 Control and Prevention (CDC), U.S. Department of Health and Human Services, Atlanta, GA 30333. Background .............................................................................. 2 Suggested Citation: Centers for Disease Control and Prevention. Infectious Diseases Designated as Notifiable at the National Level [Summary of notifiable diseases—United States, 2007]. Published July 9, During 2007* ....................................................................... 3 2009 for MMWR 2007;56(No. 53):[inclusive page numbers]. Data Sources ............................................................................ 4 Centers for Disease Control and Prevention Interpreting Data ....................................................................... 4 Richard E. Besser, MD Transition in NNDSS Data Collection and Reporting ..................... 5 (Acting) Director Tanja Popovic, MD, PhD Change in Methodology for Identifying which Nationally Notifiable Chief Science Officer Infectious Diseases were Not Reportable in Nationally Notifiable James W. Stephens, PhD Associate Director for Science Disease Surveillance System (NNDSS) Reporting Jurisdictions in Steven L. Solomon, MD 2007 .................................................................................... 5 Director, Coordinating Center for Health Information and Service Revised International Health Regulations ..................................... 6 Jay M. Bernhardt, PhD, MPH Director, National Center for Health Marketing Highlights for 2007 ................................................................... 8 Katherine L. Daniel, PhD PART 1. Summaries of Notifiable Diseases in the United States, Deputy Director, National Center for Health Marketing 2007 .................................................................................. 21 Editorial and Production Staff TABLE 1. Reported cases of notifiable diseases, by month — Frederic E. Shaw, MD, JD United States, 2007 ......................................................... 22 Editor, MMWR Series Christine G. Casey, MD TABLE 2. Reported cases of notifiable diseases, by geographic Deputy Editor, MMWR Series division and area — United States, 2007 .......................... 24 Susan F. Davis, MD TABLE 3. Reported cases and incidence of notifiable diseases, Associate Editor, MMWR Series by age group — United States, 2007 ................................ 35 Robert A. Gunn, MD, MPH Associate Editor, MMWR Series TABLE 4. Reported cases and incidence of notifiable diseases, Teresa F. Rutledge by sex — United States, 2007 .......................................... 37 Managing Editor, MMWR Series TABLE 5. Reported cases and incidence of notifiable diseases, David C. Johnson (Acting) Lead Technical Writer-Editor by race — United States, 2007......................................... 39 Suzanne M. Hewitt, MPA TABLE 6. Reported cases and incidence of notifiable diseases, Jeffrey D. Sokolow, MA by ethnicity — United States, 2007 ................................... 41 Project Editors Martha F. Boyd PART 2. Graphs and Maps for Selected Notifiable Diseases in the Lead Visual Information Specialist United States, 2007 ............................................................. 43 Kim L. Bright, MBA PART 3. Historical Summaries of Notifiable Diseases in the Quang M. Doan, MBA Phyllis H. King United States, 1976–2007 ................................................... 77 Information Technology Specialists TABLE 7. Reported incidence of notifiable diseases — United States, 1997–2007 ............................................... 78 Editorial Board William L. Roper, MD, MPH, Chapel Hill, NC, Chairman TABLE 8. Reported cases of notifiable diseases — Virginia A. Caine, MD, Indianapolis, IN United States, 2000–2007 ............................................... 80 David W. Fleming, MD, Seattle, WA William E. Halperin, MD, DrPH, MPH, Newark, NJ TABLE 9. Reported cases of notifiable diseases — King K. Holmes, MD, PhD, Seattle, WA United States, 1992–1999 ............................................... 82 Deborah Holtzman, PhD, Atlanta, GA John K. Iglehart, Bethesda, MD TABLE 10. Reported cases of notifiable diseases — Dennis G. Maki, MD, Madison, WI United States, 1984–1991 ............................................... 84 Sue Mallonee, MPH, Oklahoma City, OK Patricia Quinlisk, MD, MPH, Des Moines, IA TABLE 11. Reported cases of notifiable diseases — Patrick L. Remington, MD, MPH, Madison, WI United States, 1976–1983 ............................................... 85 Barbara K. Rimer, DrPH, Chapel Hill, NC John V. Rullan, MD, MPH, San Juan, PR TABLE 12. Deaths from selected nationally notifiable infectious William Schaffner, MD, Nashville, TN Anne Schuchat, MD, Atlanta, GA diseases – United States, 2002–2005 ............................... 86 Dixie E. Snider, MD, MPH, Atlanta, GA Selected Reading ..................................................................... 87 John W. Ward, MD, Atlanta, GA Vol. 56 / No. 53 MMWR 1 Summary of Notifiable Diseases — United States, 2007 Prepared by Patsy A. Hall-Baker, Coordinator, Summary of Notifiable Diseases1 Enrique Nieves, Jr., MS1 Ruth Ann Jajosky, DMD1 Deborah A. Adams1 Pearl Sharp1 Willie J. Anderson1 J. Javier Aponte1 Gerald F. Jones1 Aaron E. Aranas, MPH, MBA1 Araceli Rey, MPH1 Bernetta Lane, MBA1 Michael S. Wodajo2 1Division of Integrated Surveillance Systems and Services, National Center for Public Health Informatics, Coordinating Center for Health Information and Service, CDC 2McKing Consulting Corporation 2 MMWR July 9, 2009 Preface Background The Summary of Notifiable Diseases — United States, 2007 The infectious diseases designated as notifiable at the national contains the official statistics, in tabular and graphic form, level during 2007 are listed in this section. A notifiable disease for the reported occurrence of nationally notifiable infectious is one for which regular, frequent, and timely information diseases in the United States for 2007. Unless otherwise noted, regarding individual cases is considered necessary for the the data are final totals for 2007 reported as of June 30, 2008. prevention and control of the disease. A brief history of the These statistics are collected and compiled from reports sent reporting of nationally notifiable infectious diseases in the by state health departments and territories to the National United States is available at http://www.cdc.gov/ncphi/disss/ Notifiable Diseases Surveillance System (NNDSS), which is nndss/nndsshis.htm. In 1961, CDC assumed responsibility for operated by CDC in collaboration with the Council of State the collection and publication of data on nationally notifiable and Territorial Epidemiologists (CSTE). The Summary is diseases. NNDSS is neither a single surveillance system nor available at http://www.cdc.gov/mmwr/summary.html. This a method of reporting. Certain NNDSS data are reported to site also includes publications from previous years. CDC through separate surveillance information systems and The Highlights section presents noteworthy epidemiologic through different reporting mechanisms; however, these data and prevention information for 2007 for selected diseases and are aggregated and compiled for publication purposes. additional information to aid in the interpretation of surveil- Notifiable disease reporting at the local level protects the lance and disease-trend data. Part 1 contains tables showing public’s health by ensuring the proper identification and follow- incidence data for the nationally notifiable infectious diseases up of cases. Public health workers ensure that persons who are during 2007.* The tables provide the number of cases reported already ill receive appropriate treatment; trace contacts who to CDC for 2007 and the distribution of cases by month, geo- need vaccines, treatment, quarantine, or education; investigate graphic location, and the patient’s demographic characteristics and halt outbreaks; eliminate environmental hazards; and close (age, sex, race, and ethnicity). Part 2 contains graphs and maps premises where spread has occurred. Surveillance of notifiable that depict summary data for certain notifiable infectious dis- conditions helps public health authorities to monitor the eases described in tabular form in Part 1. Part 3 contains tables impact of notifiable conditions, measure disease trends, assess that list the number of cases of notifiable diseases reported to the effectiveness of control and prevention measures, identify CDC since 1976. This section also includes a table enumerating populations or geographic areas at high risk, allocate resources deaths associated with specified notifiable diseases reported to appropriately, formulate prevention strategies, and develop CDC’s National Center for Health Statistics (NCHS) during public health policies. Monitoring surveillance data enables 2002–2005. The Selected Reading section presents general public health authorities to detect sudden changes in disease and disease-specific references for notifiable infectious diseases. occurrence and distribution,
Recommended publications
  • ICD-10-CM Expert for SNF, IRF, and LTCH the Complete Official Code Set Codes Valid from October 1, 2018 Through September 30, 2019
    EXPERT 2019 ICD-10-CM Expert for SNF, IRF, and LTCH The complete official code set Codes valid from October 1, 2018 through September 30, 2019 Power up your coding optum360coding.com ITSN_ITSN19_CVR.indd 1 12/4/17 2:54 PM Contents Preface ................................................................................ iii ICD-10-CM Index to Diseases and Injuries .......................... 1 ICD-10-CM Official Preface ........................................................................iii Characteristics of ICD-10-CM ....................................................................iii ICD-10-CM Neoplasm Table ............................................ 331 What’s New for 2019 .......................................................... iv ICD-10-CM Table of Drugs and Chemicals ...................... 349 Official Updates ............................................................................................iv Proprietary Updates ...................................................................................vii ICD-10-CM Index to External Causes ............................... 397 Introduction ....................................................................... ix ICD-10-CM Tabular List of Diseases and Injuries ............ 433 History of ICD-10-CM .................................................................................ix Chapter 1. Certain Infectious and Parasitic Diseases (A00-B99) .........................................................................433 How to Use ICD-10-CM Expert for Skilled Nursing Chapter
    [Show full text]
  • ID 2 | Issue No: 4.1 | Issue Date: 29.10.14 | Page: 1 of 24 © Crown Copyright 2014 Identification of Corynebacterium Species
    UK Standards for Microbiology Investigations Identification of Corynebacterium species Issued by the Standards Unit, Microbiology Services, PHE Bacteriology – Identification | ID 2 | Issue no: 4.1 | Issue date: 29.10.14 | Page: 1 of 24 © Crown copyright 2014 Identification of Corynebacterium species Acknowledgments UK Standards for Microbiology Investigations (SMIs) are developed under the auspices of Public Health England (PHE) working in partnership with the National Health Service (NHS), Public Health Wales and with the professional organisations whose logos are displayed below and listed on the website https://www.gov.uk/uk- standards-for-microbiology-investigations-smi-quality-and-consistency-in-clinical- laboratories. SMIs are developed, reviewed and revised by various working groups which are overseen by a steering committee (see https://www.gov.uk/government/groups/standards-for-microbiology-investigations- steering-committee). The contributions of many individuals in clinical, specialist and reference laboratories who have provided information and comments during the development of this document are acknowledged. We are grateful to the Medical Editors for editing the medical content. For further information please contact us at: Standards Unit Microbiology Services Public Health England 61 Colindale Avenue London NW9 5EQ E-mail: [email protected] Website: https://www.gov.uk/uk-standards-for-microbiology-investigations-smi-quality- and-consistency-in-clinical-laboratories UK Standards for Microbiology Investigations are produced in association with: Logos correct at time of publishing. Bacteriology – Identification | ID 2 | Issue no: 4.1 | Issue date: 29.10.14 | Page: 2 of 24 UK Standards for Microbiology Investigations | Issued by the Standards Unit, Public Health England Identification of Corynebacterium species Contents ACKNOWLEDGMENTS .........................................................................................................
    [Show full text]
  • Hereditary Gingival Fibromatosiswith Hemophilia B
    Vol. 17, No ?. UDC 616.311.2:616.151.5 CODEN: ASCRBK 1983 YU ISSN: 0001—7019 Original paper Hereditary gingival fibromatosis with hemophilia B Ilija Škrinjarić, Miljenko Bačić and Zvonko Poje Department of Children’s and Preventive Dentistry, Department of Periodontology and Department of Orthodontics, Faculty of Dentistry, University of Zagreb Received, February 7, 1983 Summary This work presents a case report of a generalized form of hereditary gin­ gival fibromatosis with hemophilia B as an accompanying disease. In the family of proband, consisting of 28 members, fibromatosis was present in 9 (4 males and 5 females). The pedigree analysis confirmed that gingival fibro­ matosis was transmited through three generations as an autosomal dominant trait. Neither proband, nor any other family member, showed other abnorma­ lities. Blood coagulation tests reveald hemophilia B (Christmas disease) in the proband. The coagulogram showed prolonged kaolin cephalin time (50 se­ conds) and low concentration of factor IX (F IX 18%). The case report sug­ gests that hemophilia B should be included in the list of diseases associated with gingival fibromatosis. Key words: gingival fibromatosis, hemophilia B Hereditary gingival fibromatosis manifests as an isolated trait, accompanied by other abnormalities or disease, or as a symptom of a specific syndrome. The most common clinical abnormalities associated with gingival fibromatosis are hypertrichosis, epilepsy, mental retardation, and defects of the eye, ear, nose, skeleton and nails (Fletcher1, Gorlin et a I.2, Jorgenson and Cocker3). Isolated gingival fibromatosis without other abnormalities is considered a special entity which differs from the fibromatosis accompanied by hypertrichosis, epilepsy or mental retardation (Cohen4).
    [Show full text]
  • Attachment 2 a Risk Profile of Dairy Products in Australia Appendices 1
    2-06 22 March 2006 Attachment 2 A Risk Profile of Dairy Products in Australia Appendices 1-6 DRAFT ASSESSMENT REPORT PROPOSAL P296 PRIMARY PRODUCTION AND PROCESSING STANDARD FOR DAIRY RISK PROFILE OF DAIRY PRODUCTS IN AUSTRALIA VII APPENDICES 1. IMPACT OF PROCESSING ON DAIRY PRODUCT SAFETY 1.1 Milk and cream 1.2 Cheese 1.3 Dried milk powders 1.4 Infant formulae 1.5 Concentrated milk products 1.6 Butter and butter products 1.7 Ice cream 1.8 Cultured and fermented milk products 1.9 Dairy desserts 1.10 Dairy based dips 1.11 Casein, why products and other functional milk derivatives 1.12 Colostrum 2. EPIDEMIOLOGICAL INFORMATION ON OUTBREAKS OF FOODBORNE ILLNESS ASSOCIATED WITH DAIRY PRODUCTS 3. OCCURRENCE OF MICROBIOLOGICAL HAZARDS ASSOCIATED WITH DAIRY PRODUCTS 4. CONSUMPTION FIGURES OF DAIRY PRODUCTS FOR AUSTRALIAN CONSUMERS 5. HAZARD IDENTIFICATION/HAZARD CHARACTERISATION OF PATHOGENS 5.1 Aeromonas Spp. 5.2 Bacillus cereus 5.3 Brucella Spp. 5.4 Campylobacter jejuni/coli 5.5 Clostridium Spp. 5.6 Coxiella burnetii 5.7 Corynebacterium ulcerans 5.8 Cryptosporidium 5.9 Enterobacter sakazakii 5.10 Pathogenic Escherichia coli 5.11 Listeria monocytogenes 5.12 Mycobacterium bovis 5.13 Mycobacterium avium subsp. paratuberculosis 5.14 Salmonella Spp. 5.15 Shigella Spp. 5.16 Staphylococcus aureus 5.17 Streptococcus Spp. 5.18 Yersinia enterocolitica 6. PREVIOUS RISK ASSESSMENTS ON MICROBIOLOGICAL PATHOGENS IN DAIRY PRODUCTS 7. CHEMICAL RISK ASSESSMENT FRAMEWORK 8. REGULATORY FRAMEWORK FOR AGRICULTURAL AND VETERINARY CHEMICALS 9. MAXIMUM RESIDUE LIMITS 10. CHEMICAL RESIDUES MEASURED IN BOVINE DAIRY PRODUCTS 11. REGISTERED ANTIMICROBIAL AGENTS 12.
    [Show full text]
  • European Conference on Rare Diseases
    EUROPEAN CONFERENCE ON RARE DISEASES Luxembourg 21-22 June 2005 EUROPEAN CONFERENCE ON RARE DISEASES Copyright 2005 © Eurordis For more information: www.eurordis.org Webcast of the conference and abstracts: www.rare-luxembourg2005.org TABLE OF CONTENT_3 ------------------------------------------------- ACKNOWLEDGEMENTS AND CREDITS A specialised clinic for Rare Diseases : the RD TABLE OF CONTENTS Outpatient’s Clinic (RDOC) in Italy …………… 48 ------------------------------------------------- ------------------------------------------------- 4 / RARE, BUT EXISTING The organisers particularly wish to thank ACKNOWLEDGEMENTS AND CREDITS 4.1 No code, no name, no existence …………… 49 ------------------------------------------------- the following persons/organisations/companies 4.2 Why do we need to code rare diseases? … 50 PROGRAMME COMMITTEE for their role : ------------------------------------------------- Members of the Programme Committee ……… 6 5 / RESEARCH AND CARE Conference Programme …………………………… 7 …… HER ROYAL HIGHNESS THE GRAND DUCHESS OF LUXEMBOURG Key features of the conference …………………… 12 5.1 Research for Rare Diseases in the EU 54 • Participants ……………………………………… 12 5.2 Fighting the fragmentation of research …… 55 A multi-disciplinary approach ………………… 55 THE EUROPEAN COMMISSION Funding of the conference ……………………… 14 Transfer of academic research towards • ------------------------------------------------- industrial development ………………………… 60 THE GOVERNEMENT OF LUXEMBOURG Speakers ……………………………………………… 16 Strengthening cooperation between academia
    [Show full text]
  • National System for Recording and Notification of Occupational Diseases Practical Guide
    InternationalInternational LabourLabour OfficeOffice GenevaGeneva National System for Recording and Notification of Occupational Diseases Practical guide Programme on Safety and Health at Work and the Environment (SafeWork) International Labour Organization Route des Morillons 4 CH -1211 Geneva 22 Switzerland TEL. + 41 22 7996715 FAX + 41 22 7996878 E-mail : safework @ ilo.org www.ilo.org / safework ILO National System for Recording and Notification of Occupational Diseases – Practical guide ISBN 978-92-2-127057-7 9 789221 270577 Programme on Safety and Health at Work and the Environment (SafeWork) National System for Recording and Notification of Occupational Diseases Practical guide International Labour Office, Geneva Copyright © International Labour Organization 2013 First published 2013 Publications of the International Labour Office enjoy copyright under Protocol 2 of the Universal Copyright Convention. Never- theless, short excerpts from them may be reproduced without authorization, on condition that the source is indicated. For rights of reproduction or translation, application should be made to ILO Publications (Rights and Permissions), International Labour Office, CH-1211 Geneva 22, Switzerland, or by email: [email protected]. The International Labour Office welcomes such applications. Libraries, institutions and other users registered with reproduction rights organizations may make copies in accordance with the licences issued to them for this purpose. Visit www.ifrro.org to find the reproduction rights organization in your country.
    [Show full text]
  • LIST of OCCUPATIONAL DISEASES (Revised 2010)
    LIST OF OCCUPATIONAL DISEASES (revised 2010) Identification and recognition of occupational diseases: Criteria for incorporating diseases in the ILO list of occupational diseases Occupational Safety and Health Series, No. 74 List of occupational diseases (revised 2010) Identification and recognition of occupational diseases: Criteria for incorporating diseases in the ILO list of occupational diseases INTERNATIONAL LABOUR OFFICE • GENEVA Copyright © International Labour Organization 2010 First published 2010 Publications of the International Labour Office enjoy copyright under Protocol 2 of the Universal Copyright Convention. Nevertheless, short excerpts from them may be reproduced without authorization, on condition that the source is indicated. For rights of reproduction or translation, application should be made to ILO Publications (Rights and Permissions), International Labour Office, CH-1211 Geneva 22, Switzerland, or by email: pubdroit@ ilo.org. The International Labour Office welcomes such applications. Libraries, institutions and other users registered with reproduction rights organizations may make copies in accordance with the licences issued to them for this purpose. Visit www.ifrro.org to find the reproduction rights organization in your country. ILO List of occupational diseases (revised 2010). Identification and recognition of occupational diseases: Criteria for incorporating diseases in the ILO list of occupational diseases Geneva, International Labour Office, 2010 (Occupational Safety and Health Series, No. 74) occupational disease / definition. 13.04.3 ISBN 978-92-2-123795-2 ISSN 0078-3129 Also available in French: Liste des maladies professionnelles (révisée en 2010): Identification et reconnaissance des maladies professionnelles: critères pour incorporer des maladies dans la liste des maladies professionnelles de l’OIT (ISBN 978-92-2-223795-1, ISSN 0250-412x), Geneva, 2010, and in Spanish: Lista de enfermedades profesionales (revisada en 2010).
    [Show full text]
  • ICD-10 International Statistical Classification of Diseases and Related Health Problems
    ICD-10 International Statistical Classification of Diseases and Related Health Problems 10th Revision Volume 2 Instruction manual 2010 Edition WHO Library Cataloguing-in-Publication Data International statistical classification of diseases and related health problems. - 10th revision, edition 2010. 3 v. Contents: v. 1. Tabular list – v. 2. Instruction manual – v. 3. Alphabetical index. 1.Diseases - classification. 2.Classification. 3.Manuals. I.World Health Organization. II.ICD-10. ISBN 978 92 4 154834 2 (NLM classification: WB 15) © World Health Organization 2011 All rights reserved. Publications of the World Health Organization are available on the WHO web site (www.who.int) or can be purchased from WHO Press, World Health Organization, 20 Avenue Appia, 1211 Geneva 27, Switzerland (tel.: +41 22 791 3264; fax: +41 22 791 4857; e-mail: [email protected]). Requests for permission to reproduce or translate WHO publications – whether for sale or for noncommercial distribution – should be addressed to WHO Press through the WHO web site (http://www.who.int/about/licensing/copyright_form). The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned.
    [Show full text]
  • Diseases of the Canine Digit
    Diseases of the Canine Digit Diseases of the digit are relatively common and are particularly frustrating in terms of therapy. Unlike many other areas of skin, persisting diseases of the digit will almost always require biopsy to distinguish among a very long list of radically different etiologic possibilities. One cannot tell, just by looking at it, whether the digital swelling is chronic inflammation or squamous cell carcinoma, or whether the lump on the side of the digit is a harmless plasmacytoma or a potentially fatal amelanotic malignant melanoma. 1. Multiple nails that are brittle, deformed, or fall out: Most textbooks will provide a very long list of diseases of the nail and nail bed, but in practical terms I see only one syndrome: lupoid onychodystrophy. Bacterial and fungal paronychia, for example, is so rare in my collection that I have some skepticism that it even exists! The syndrome of lupoid onychodystrophy is seen in young mature dogs (1-5 years), and these animals present with a complaint of deformed nails that are periodically lost. The disease affects multiple digits on multiple feet, often eventually affecting all nails on all feet. The lesion is a lupus-like destructive disease (lymphocytic interface dermatitis with single cell necrosis) of the basal cells of the nail bed epithelium. As is true with similar histologic reactions affecting the nasal planum, gingiva, or conjunctiva, it is not yet clear whether this highly repeatable histologic pattern is really a reflection of a single disease, or is simply the way that the nail bed epithelium responds to a variety of different injuries.
    [Show full text]
  • NGS-Based Phylogeny of Diphtheria-Related Pathogenicity Factors in Different Corynebacterium Spp
    Dangel et al. BMC Microbiology (2019) 19:28 https://doi.org/10.1186/s12866-019-1402-1 RESEARCHARTICLE Open Access NGS-based phylogeny of diphtheria-related pathogenicity factors in different Corynebacterium spp. implies species- specific virulence transmission Alexandra Dangel1* , Anja Berger1,2*, Regina Konrad1 and Andreas Sing1,2 Abstract Background: Diphtheria toxin (DT) is produced by toxigenic strains of the human pathogen Corynebacterium diphtheriae as well as zoonotic C. ulcerans and C. pseudotuberculosis. Toxigenic strains may cause severe respiratory diphtheria, myocarditis, neurological damage or cutaneous diphtheria. The DT encoding tox gene is located in a mobile genomic region and tox variability between C. diphtheriae and C. ulcerans has been postulated based on sequences of a few isolates. In contrast, species-specific sequence analysis of the diphtheria toxin repressor gene (dtxR), occurring both in toxigenic and non-toxigenic Corynebacterium species, has not been done yet. We used whole genome sequencing data from 91 toxigenic and 46 non-toxigenic isolates of different pathogenic Corynebacterium species of animal or human origin to elucidate differences in extracted DT, DtxR and tox-surrounding genetic elements by a phylogenetic analysis in a large sample set. Results: Sequences of both DT and DtxR, extracted from whole genome sequencing data, could be classified in four distinct, nearly species-specific clades, corresponding to C. diphtheriae, C. pseudotuberculosis, C. ulcerans and atypical C. ulcerans from a non-toxigenic toxin gene-bearing wildlife cluster. Average amino acid similarities were above 99% for DT and DtxR within the four groups, but lower between them. For DT, subgroups below species level could be identified, correlating with different tox-comprising mobile genetic elements.
    [Show full text]
  • FAQ REGARDING DISEASE REPORTING in MONTANA | Rev
    Disease Reporting in Montana: Frequently Asked Questions Title 50 Section 1-202 of the Montana Code Annotated (MCA) outlines the general powers and duties of the Montana Department of Public Health & Human Services (DPHHS). The three primary duties that serve as the foundation for disease reporting in Montana state that DPHHS shall: • Study conditions affecting the citizens of the state by making use of birth, death, and sickness records; • Make investigations, disseminate information, and make recommendations for control of diseases and improvement of public health to persons, groups, or the public; and • Adopt and enforce rules regarding the reporting and control of communicable diseases. In order to meet these obligations, DPHHS works closely with local health jurisdictions to collect and analyze disease reports. Although anyone may report a case of communicable disease, such reports are submitted primarily by health care providers and laboratories. The Administrative Rules of Montana (ARM), Title 37, Chapter 114, Communicable Disease Control, outline the rules for communicable disease control, including disease reporting. Communicable disease surveillance is defined as the ongoing collection, analysis, interpretation, and dissemination of disease data. Accurate and timely disease reporting is the foundation of an effective surveillance program, which is key to applying effective public health interventions to mitigate the impact of disease. What diseases are reportable? A list of reportable diseases is maintained in ARM 37.114.203. The list continues to evolve and is consistent with the Council of State and Territorial Epidemiologists (CSTE) list of Nationally Notifiable Diseases maintained by the Centers for Disease Control and Prevention (CDC). In addition to the named conditions on the list, any occurrence of a case/cases of communicable disease in the 20th edition of the Control of Communicable Diseases Manual with a frequency in excess of normal expectancy or any unusual incident of unexplained illness or death in a human or animal should be reported.
    [Show full text]
  • PREVENTING DISEASE THROUGH HEALTHY ENVIRONMENTS This Report Summarizes the Results Globally, by 14 Regions Worldwide, and Separately for Children
    How much disease could be prevented through better management of our environment? The environment influences our health in many ways — through exposures to physical, chemical and biological risk factors, and through related changes in our behaviour in response to those factors. To answer this question, the available scientific evidence was summarized and more than 100 experts were consulted for their estimates of how much environmental risk factors contribute to the disease burden of 85 diseases. PREVENTING DISEASE THROUGH HEALTHY ENVIRONMENTS This report summarizes the results globally, by 14 regions worldwide, and separately for children. Towards an estimate of the environmental burden of disease The evidence shows that environmental risk factors play a role in more than 80% of the diseases regularly reported by the World Health Organization. Globally, nearly one quarter of all deaths and of the total disease burden can be attributed to the environment. In children, however, environmental risk factors can account for slightly more than one-third of the disease burden. These findings have important policy implications, because the environmental risk factors that were studied largely can be modified by established, cost-effective interventions. The interventions promote equity by benefiting everyone in the society, while addressing the needs of those most at risk. ISBN 92 4 159382 2 PREVENTING DISEASE THROUGH HEALTHY ENVIRONMENTS - Towards an estimate of the environmental burden of disease ENVIRONMENTS - Towards PREVENTING DISEASE THROUGH HEALTHY WHO PREVENTING DISEASE THROUGH HEALTHY ENVIRONMENTS Towards an estimate of the environmental burden of disease A. Prüss-Üstün and C. Corvalán WHO Library Cataloguing-in-Publication Data Prüss-Üstün, Annette.
    [Show full text]